Avastin shouldn't make the FDA give up on 'accelerated approval' of drugs (L.A. Times)
By Jeff Stier, Esq., and Dr. Henry I. Miller
Publish Date : Tuesday, August 17, 2010
By Henry I. Miller and Jeff Stier. An important but obscure aspect of the Food and Drug Administration's regulation of drugs offers a mechanism for lifesaving medicines to quickly reach the marketplace without going through a time-consuming approval process.  Read Full >>

Bad Ads, Badder FDA (from Medical Progress Today)
By Elizabeth M. Whelan, Sc.D., M.P.H.
Publish Date : Thursday, June 3, 2010
By Dr. Elizabeth Whelan. No one wants misleading pharmaceutical advertising, but the Food and Drug Administration's plan to deputize doctors to police drug companies is a misguided effort.  Read Full >>

Is There Such a Thing as an Objective Science Journal? (from the Daily Caller)
By Jeff Stier, Esq.
Type : Editorial
Publish Date : Thursday, February 25, 2010
By Jeff Stier.  A journal’s ability to tell good science from bad is critical. But some journals have used poor judgment...  Read Full >>

Junk Science Kills (from the New York Post and The Week)
Who'll Apologize to Dead Kids?
By Elizabeth M. Whelan, Sc.D., M.P.H.
Type : Editorial
Publish Date : Thursday, February 4, 2010
By Dr. Elizabeth Whelan. The media gave big headlines to this week's stories on a prestigious British medical publication's retraction of an article that had claimed to show a causal link between standard childhood vaccinations (measles, mumps and rubella) and autism. Yet the coverage of the Lancet affair didn't truly convey the outrageousness of the original publication or the gravity of its consequences...  Read Full >>

Conflict of Interest (from Medical Progress Today)
By Elizabeth M. Whelan, Sc.D., M.P.H.
Type : Editorial
Publish Date : Thursday, January 28, 2010
By Dr. Elizabeth Whelan.  The pharmaceutical industry is a powerful innovative force, both in the creation of new life-saving technologies and the underwriting of academic medical research. Yet there is now a sweeping "conflicts of interest" movement aimed squarely at curtailing academic-industry collaboration in biomedical research...  Read Full >>